tiprankstipranks
Theravance Biopharma (TBPH)
NASDAQ:TBPH
Holding TBPH?
Track your performance easily

Theravance Biopharma (TBPH) Financial Statements

312 Followers

Theravance Biopharma Financial Overview

Theravance Biopharma's market cap is currently ―. The company's EPS TTM is $-1.011; its P/E ratio is -9.14; Theravance Biopharma is scheduled to report earnings on March 3, 2025, and the estimated EPS forecast is $-0.20. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 16.87M$ 14.26M$ 14.50M$ 17.57M$ 15.69M
Gross Profit$ 16.87M$ 14.26M$ 14.50M$ 23.83M$ 15.69M
EBIT$ -10.05M$ -15.22M$ -9.77M-$ -6.97M
EBITDA$ -9.29M$ -14.24M$ -8.59M-$ -6.04M
Net Income Common Stockholders$ -12.70M$ -15.88M$ -11.66M$ -2.25M$ -8.95M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 91.36M$ 96.08M$ 99.97M$ 102.43M$ 134.00M
Total Assets$ 356.11M$ 362.03M$ 371.31M$ 382.00M$ 413.59M
Total Debt$ 44.98M$ 46.66M$ 47.90M$ 49.16M$ 50.83M
Net Debt$ -46.38M$ -49.42M$ -52.07M$ -53.27M$ -83.17M
Total Liabilities$ 170.45M$ 168.34M$ 166.44M$ 169.00M$ 167.46M
Stockholders Equity$ 185.65M$ 193.69M$ 204.87M$ 213.00M$ 246.13M
Cash Flow-
Free Cash Flow$ -5.21M$ -4.45M$ -1.11M-$ -2.51M
Operating Cash Flow$ -5.20M$ -4.42M$ -1.02M$ -854.00K$ -2.49M
Investing Cash Flow$ -17.40M$ -3.03M$ 17.03M$ -677.00K$ -21.00K
Financing Cash Flow$ -372.00K$ -44.00K$ -1.72M$ -30.61M$ -31.40M
Currency in USD

Theravance Biopharma Earnings and Revenue History

Theravance Biopharma Debt to Assets

Theravance Biopharma Cash Flow

Theravance Biopharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis